Apoptosis signal‐regulating kinase‐1 inhibitor as a potent therapeutic drug for the treatment of gastric cancer

Aside from the human epidermal growth factor receptor‐2 (HER2)‐targeting agent trastuzumab, molecular targeting therapy for gastric cancer (GC) has not been established. We previously reported that apoptosis signal‐regulating kinase‐1 (ASK1) was upregulated in human GC and that overexpression of ASK...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Sci
Main Authors: Hayakawa, Yoku, Hirata, Yoshihiro, Sakitani, Kosuke, Nakagawa, Hayato, Nakata, Wachiko, Kinoshita, Hiroto, Takahashi, Ryota, Takeda, Kohsuke, Ichijo, Hidenori, Maeda, Shin, Koike, Kazuhiko
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2012
Assuntos:
Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659227/
https://ncbi.nlm.nih.gov/pubmed/23110662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12024
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares